Honey and black cumin found to treat H. Pylori patients
(Natural News) Helicobacter pylori – or H. pylori – infections are fairly common, with more than half the world’s population likely walking around with these bacteria in their gut. Nonetheless, they are responsible for the majority of ulcers of the small intestine and stomach, and are becoming increasingly difficult to treat. New “superbug” type antibiotic-resistant strains... (Source: NaturalNews.com)
Source: NaturalNews.com - March 9, 2019 Category: Consumer Health News Source Type: news

Infection biology: What makes Helicobacter so adaptable?
(Ludwig-Maximilians-Universit ä t M ü nchen) The bacterial pathogen Helicobacter pylori owes its worldwide distribution to its genetic adaptability. Ludwig-Maximilians-Universitaet Munich microbiologists have identified an enzyme that plays a vital role in the flexible control of global gene expression in the species. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 12, 2019 Category: Infectious Diseases Source Type: news

Houston Consensus Conference on H. pylori Infection Testing Houston Consensus Conference on H. pylori Infection Testing
This paper presents guidelines for implementing testing for H. pylori infection in U.S. health care systems, with a focus on identifying target populations for diagnosis and therapy.Clinical Gastroenterology and Hepatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 10, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Metformin Tied to Lower Gastric Cancer Risk After H. Pylori Eradication Metformin Tied to Lower Gastric Cancer Risk After H. Pylori Eradication
Metformin use is associated with a lower risk of gastric cancer in diabetic patients after eradication of H. pylori, researchers from Hong Kong report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 7, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Mangoes for digestive health: A compound found in the fruit was found to be effective against H. pylori
(Natural News) The next big thing in cancer treatment might just come from a fruit we all know — mangoes. A study published in the African Journal of Traditional, Complementary and Alternative Medicines revealed that mangiferin, a bioactive compound found in mangoes, may reduce the likelihood of gastric cancer induced by the bacteria Helicobacter pylori (H. pylori). In... (Source: NaturalNews.com)
Source: NaturalNews.com - October 27, 2018 Category: Consumer Health News Source Type: news

H. Pylori Antibodies May Point to Colorectal Cancer Risk H. Pylori Antibodies May Point to Colorectal Cancer Risk
Antibodies to Vacuolating cytotoxin A (VacA), one of the major toxins secreted by Helicobacter pylori, show a relationship with colorectal cancer, according to a large study of serum.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - October 23, 2018 Category: Pathology Tags: Gastroenterology News Source Type: news

H. Pylori Ups CRC Risk in Some Ethnic Groups
(MedPage Today) -- And high antibody levels tied to greater incidence in black and Asian patients (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - October 15, 2018 Category: Gastroenterology Source Type: news

Pilot study identifies strain of bacteria as chief risk factor for stomach cancer
(Fred Hutchinson Cancer Research Center) Researchers at Fred Hutchinson Cancer Research Center have found a specific strain of Helicobacter pylori strongly correlated with stomach cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 12, 2018 Category: International Medicine & Public Health Source Type: news

ASA and Risk of Gastric Cancer After H pylori Eradication ASA and Risk of Gastric Cancer After H pylori Eradication
Does aspirin reduce the risk of gastric cancer in patients with a history of H pylori?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 31, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

With Three Guidelines on H pylori, What Should Clinicians Do? With Three Guidelines on H pylori, What Should Clinicians Do?
Helicobacter pylori has been the subject of countless recommendations for best practice management. A brief review of some changes reflected in three guidelines is provided to help clinicians.Medscape Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 29, 2018 Category: Consumer Health News Tags: Gastroenterology Viewpoint Source Type: news

Medical News Today: What are the best natural H. pylori treatments?
The bacteria H. pylori can cause a range of gastrointestinal issues, including gastritis. Infection may even lead to gastric cancer. Fortunately, there are many natural ways to help treat it, including honey, aloe vera, broccoli sprouts, and lemongrass oil. Learn about eight natural treatments for H. pylori here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 31, 2018 Category: Consumer Health News Tags: GastroIntestinal / Gastroenterology Source Type: news

Global Resistance to Anti-H. Pylori Drugs Rising (CME/CE)
(MedPage Today) -- Regionally targeted eradication regimens are needed, researchers say (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - July 13, 2018 Category: American Health Source Type: news

Houston Consensus Shrinks Gaps in H. Pylori Management (CME/CE)
(MedPage Today) -- 29 new recommendations to help eliminate active disease especially in at-risk subgroups (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 27, 2018 Category: Primary Care Source Type: news

Antibiotic Resistance and Efficacy of Therapy for H. Pylori Antibiotic Resistance and Efficacy of Therapy for H. Pylori
How prevalent is primary resistance to the three antimicrobial agents most commonly used in H. pylori eradication regimens? Is sequential therapy an effective option to improve outcomes?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 26, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Helicobacter Pylori: A Better Test, Low Cure Rates, High Resistance - 3 Studies from DDW
Highlights of H. pylori-focused research at Digestive Disease Week: a noninvasive assessment tool, need for eradication testing, and patterns of treatment resistance.   (Source: ConsultantLive)
Source: ConsultantLive - June 10, 2018 Category: Internal Medicine Authors: Veronica Hackethal, MD Tags: Conferences/Digestive Disease Week Source Type: news

Study: Disease-causing stomach bug attacks energy generation in host cells
(University of Illinois at Urbana-Champaign) Researchers report in a new study that the bacterium Helicobacter pylori -- a major contributor to gastritis, ulcers and stomach cancer -- resists the body's immune defenses by shutting down energy production within the cells of the stomach lining that serve as a barrier to infection. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 30, 2018 Category: Infectious Diseases Source Type: news

Bacterial manipulation of host cell metabolism
A Helicobacter pylori exotoxin manipulates host cell metabolism by inducing amino acid starvation and inhibiting mTORC1 signaling. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - May 29, 2018 Category: Science Authors: VanHook, A. M. Tags: STKE Editors ' Choice Source Type: news

Durham pharma eyes potential approval of drug in roughly $5B market
RedHill Biopharma (Nasdaq: RDHL) – which continued to grow its U.S. commercial operations based in Raleigh over the course of 2017 – has its sights set on potential approval of a drug in a market worth roughly $5 billion.  RedHill expects to compete enrollment of close to 450 patients in an ongoing Phase III study for its dru g candidate TALICIA for the treatment of H. pylori infection – which can cause chronic gastritis, ulcers and gastric cancer – in the third quarter of this year. As… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 7, 2018 Category: Biotechnology Authors: Jennifer Henderson Source Type: news

H. Pylori Linked to Atherosclerosis in Healthy People (CME/CE)
(MedPage Today) -- Infected individuals with no history of coronary heart disease had significant subclinical atherosclerosis (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 31, 2018 Category: Cardiology Source Type: news

Consensus Details H pylori Testing, Treatment for US Patients Consensus Details H pylori Testing, Treatment for US Patients
Consensus document outlines who should be tested and treated for H pylori infection to reduce adverse health consequences of long-term infection.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 29, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Orthotics and Heel Pain; Bacteria and Cancer: It's PodMed Double T! (with audio)
(MedPage Today) -- This week's topics include infants with bronchiolitis, orthotics for heel pain, behavioral therapy in dementia, and H. pylori infection in early gastric cancer (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - March 24, 2018 Category: Psychiatry Source Type: news

Treating H. Pylori Cuts Metachronous Cancer Rate
(MedPage Today) -- 50% reduction in endoscopically resected gastric cancer (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 22, 2018 Category: Gastroenterology Source Type: news

H pylori Eradication Benefits Patients With Early Gastric Cancer H pylori Eradication Benefits Patients With Early Gastric Cancer
Patients with early gastric cancer treated for Helicobacter pylori had a lower incidence of metachronous gastric cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 21, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Exalenz Bioscience’s BreathID(R) Hp and BreathID Hp Lab Systems Receive FDA Clearance for Diagnosis of Helicobacter pylori Testing in Pediatric Patients
Important new testing option for an infection that impacts nearly 20 million U.S. children and may have significant negative impacts on long-term health MODI'IN, Israel and MANASQUAN, N.J., March 13, 2018 -- (Healthcare Sales & Marketing Network) -- Exa... Diagnostics, FDA Exalenz Bioscience, BreathID, Helicobacter pylori, H. pylori (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 13, 2018 Category: Pharmaceuticals Source Type: news

The Proven & Unproven Health Benefits Of Honey
By Sandee LaMotte, CNN (CNN) — Move over, prehistoric bears. Humans have loved honey since the Stone Age. Rock art pictures of honey harvesting, which at first glance look like drawings from A.A. Milne’s Winnie-the-Pooh, date to about 8000 B.C. Beeswax has been found on pottery dating as far back as 7000 B.C., most likely used for waterproofing. The ancient Egyptians offered honey to the gods and then joined the Greeks, Romans and Chinese in using it as a salve for wounds and a treatment for fevers and stomach ailments. Today, proponents of honey tout its miraculous healing properties, claiming that it can prev...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 20, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Honey Source Type: news

< i > H. pylori < /i > ( < i > Helicobacter Pylori < /i > ) Infection Symptoms, Test, Treatment
Title:H. pylori (Helicobacter Pylori ) Infection Symptoms, Test, TreatmentCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 1/9/2018 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - January 9, 2018 Category: Nutrition Source Type: news

H. Pylori Eludes Immune Response Via Cholesterol Depletion H. Pylori Eludes Immune Response Via Cholesterol Depletion
Manipulation of cell cholesterol levels allows Helicobacter pylori to escape full elimination by host immunity, according to German researchers.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 2, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Illusions Regarding H. pylori Trials and Treatment Guidelines Illusions Regarding H. pylori Trials and Treatment Guidelines
In this commentary, the author points out major flaws in treatment studies and meta-analyses pertaining to H. pylori eradication therapy. Are we overlooking the most important detail?Gut (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 14, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Gastric cancer: A new strategy used by Helicobacter pylori to target mitochondria
(Institut Pasteur) Scientists from the Institut Pasteur and CNRS have recently identified new strategies used by Helicobacter pylori bacteria to infect cells. By specifically targeting mitochondria these bacteria, despite being extracellular, can optimize infection in the host. These findings pave the way for new strategies to combat H. pylori infection, which is associated with most cases of gastric cancer and several other gastric disorders. The results were published on Nov. 21 in the journal Scientific Reports. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 28, 2017 Category: Cancer & Oncology Source Type: news

The Global Recurrence Rate of Helicobacter Pylori The Global Recurrence Rate of Helicobacter Pylori
Is the recurrence rate following H. pylori eradication therapy associated with socioeconomic and sanitary conditions?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 24, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Shape-shifting agent targets harmful bacteria in the stomach
(University of Illinois at Urbana-Champaign) A new shape-shifting polymer can target and kill Helicobacter pylori bacteria in the stomach without killing helpful bacteria in the gut. Such a treatment could improve the digestive health of billions of people worldwide who contract H. pylori infections. The antimicrobial agent morphs into a bacterial hole-puncher in the stomach's acidic environment and reverts to an amorphous, inactive structure when it reaches the higher pH environment of the small intestine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 14, 2017 Category: International Medicine & Public Health Source Type: news

How Helicobacter pylori causes gastric cancer
(University of Erlangen-Nuremberg) Gastric cancer is one of the five most fatal types of cancer. According to the statistics of the World Health Organization about 750,000 patients die each year after developing the disease. The main cause is thought to be the bacterium Helicobacter pylori. Researchers at Friedrich-Alexander-Universit ä t Erlangen-N ü rnberg (FAU) have now identified two mechanisms through which this bacterium can cause gastric cancer. Their findings could result in the development of new therapeutic approaches. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 7, 2017 Category: Cancer & Oncology Source Type: news

Acid reflux drugs linked to increased stomach cancer risk
Conclusion PPIs are commonly used medicines for acid reflux. This may seem like alarming news for the many people in the UK who take them, but it's important to remember that the overall risk of stomach cancer is still very low. This study has several limitations that mean we should be cautious about the results: This type of study can't prove PPIs caused the increased risk of cancer. The increased risk could be down to other factors. Researchers were unable to adjust their figures to take account of some relevant confounding factors, such as alcohol and tobacco use, as these weren't routinely recorded. Almost all the pati...
Source: NHS News Feed - November 1, 2017 Category: Consumer Health News Tags: Cancer Source Type: news

PPI Use After H. pylori Eradication Therapy Tied to Increased Risk for Gastric Cancer (FREE)
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Long-term use of proton-pump inhibitors (PPIs) after treatment for Helicobacter pylori infection is associated with increased risk for gastric cancer, according to a … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 1, 2017 Category: Primary Care Source Type: news

Long-term use of PPIs linked to doubling in stomach cancer risk
Risk rose with dose and duration of treatment after H pylori eradication Related items fromOnMedica Proton pump inhibitors associated with raised mortality Oesophageal and stomach cancer linked to early adulthood overweight Experts link alcohol to stomach cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 1, 2017 Category: UK Health Source Type: news

Heartburn Drugs Tied to Stomach Cancer Risk
After treatment for H. pylori infection, people who took proton pump inhibitors were at increased risk of stomach cancer. (Source: NYT Health)
Source: NYT Health - November 1, 2017 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Stomach Cancer Ulcers Heartburn Bacteria Helicobacter Pylori (Bacterium) Source Type: news

Gastric Cancer Risk Doubled With Long-term PPI Use Gastric Cancer Risk Doubled With Long-term PPI Use
The risk for gastric cancer increases with the dose and duration of proton-pump inhibitor use after successful H pylori eradication.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 31, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Long-term PPI Use Tied to Doubled Risk for Gastric Cancer Long-term PPI Use Tied to Doubled Risk for Gastric Cancer
The risk for gastric cancer increases with the dose and duration of proton-pump inhibitor use after successful H pylori eradication.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 31, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Is H. pylori Contagious? Symptoms and Tests
Title: Is H. pylori Contagious? Symptoms and TestsCategory: Diseases and ConditionsCreated: 5/14/2015 12:00:00 AMLast Editorial Review: 10/31/2017 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - October 31, 2017 Category: Nutrition Source Type: news

Bacteria eradication reduces gastric cancer risk by 22 percent in over-60s, new research shows
(Spink Health) The research analyzed the risk of gastric cancer development in a large group of individuals who had received antibiotic therapy to treat H. pylori infection. Of those who had been treated over the age of 60, 0.8 percent developed gastric cancer, in comparison to 1.1 percent of patients in an age-matched general population sample. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 30, 2017 Category: Cancer & Oncology Source Type: news

Helicobacter pylori: Dodging the bullet
(Ludwig-Maximilians-Universit ä t M ü nchen) Helicobacter pylori is a widespread bacterial pathogen that infects the lining of the stomach, where it can cause ulcers and even cancer. As a new study shows, its genetic variability complicates efforts to develop an effective vaccine. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 25, 2017 Category: Biology Source Type: news

Gut bacterium indirectly causes symptoms by altering fruit fly microbiome
(PLOS) CagA, a protein produced by the bacterium Helicobacter pylori, can alter the population of microbes living in the fruit fly gut, leading to disease symptoms, according to new research published in PLOS Pathogens by Tiffani Jones and Karen Guillemin of the University of Oregon. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 19, 2017 Category: Infectious Diseases Source Type: news

Country-specific Antibiotic Resistance Strategies Advocated for H. Pylori in Asia-Pacific Country-specific Antibiotic Resistance Strategies Advocated for H. Pylori in Asia-Pacific
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 18, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

UC consortium formed to speed up development of new drugs
For 12 years, UCLA researcher Dennis Slamon pursued a groundbreaking approach to treating breast cancer: Attack the disease genetically.The journey was long and filled with obstacles, but his persistence paid off.Slamon and colleagues conducted laboratory and clinical research that, in collaboration with biotechnology firm Genentech, helped lead to development of the breast cancer drug Herceptin.UCLA's Dennis Slamon with Harry Connick Jr., who played the professor of medicine in a 2008 television movie.The drug, which targets a specific genetic alteration found in about 25 percent of breast cancer patients, has saved thous...
Source: UCLA Newsroom: Health Sciences - June 21, 2017 Category: Universities & Medical Training Source Type: news

RedHill Biopharma commences Phase III trial of RHB-105 to treat H. pylori infection
Israeli-based specialist biopharmaceutical firm RedHill Biopharma has commenced a confirmatory Phase III ERADICATE Hp 2 clinical trial of RHB-105 (Talicia) for the treatment of patients with Helicobacter pylori (H. pylori) infection. (Source: Drug Development Technology)
Source: Drug Development Technology - June 16, 2017 Category: Pharmaceuticals Source Type: news

UA researchers find physicians' adherence to H. pylori guidelines low
(University of Arizona) It was long thought that gastric ulcers and other digestive woes were brought about by stress. But in 2005, clinical fellow Barry J. Marshall and pathologist J. Robin Warren were awarded the Nobel Prize in Physiology or Medicine for recognizing the role of Helicobacter pylori in gastritis and peptic ulcer disease. Now physicians can point their collective fingers at H. pylori when it comes to a host of gastric maladies in their patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2017 Category: International Medicine & Public Health Source Type: news

This nanofiber device can hear cells moving
This is an artist’s illustration of nano optical fibers detecting femtonewton-scale forces produced by swimming bacteria. [Image from Rhett S. Miller/UC Regents]A new miniature nanofiber device created by engineers at the University of California at San Diego is sensitive enough that it can feel bacteria swimming and can hear heart muscle cells beating. The device is 100 times thinner than a human hair and is made of optical fiber. It is designed to be able to detect forces as small as 160 fN if put in a live Helicobacter pylori bacteria solution. The device can also hear sounds at –30 dB, which is 1,...
Source: Mass Device - May 30, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Diagnostics Research & Development Nanotechnology UC San Diego University of California San Diego Source Type: news

Medical News Today: Diet tips for gastritis and stomach ulcers
Gastritis is commonly caused by an infection of the bacteria H.pylori. Learn about which foods to eat and which to avoid in order to minimize symptoms. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 20, 2017 Category: Consumer Health News Tags: GastroIntestinal / Gastroenterology Source Type: news

These 3 Superbugs Pose The Greatest Risk To Human Health
The World Health Organization is issuing a warning about a group of deadly bacteria: Recently, the WHO released its first-ever list of “priority pathogens,” a list of antibiotic-resistant bacteria that the organization says pose the greatest threat to human health. The list is divided into three categories: critical-, high- and medium-priority. Three pathogens made it into the critical-priority group. These bacteria are resistant to multiple antibiotics and pose a high risk to people in hospitals and nursing homes, the WHO says. Multidrug-resistant bacteria, sometimes called “superbugs,” are a ...
Source: Science - The Huffington Post - March 23, 2017 Category: Science Source Type: news